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Abstract - The rheological properties of pharmaceutical 
formulations intended for liquid fill hard gelatin 
capsules are fundamental for their filling performance. 
Here we used the rheological characteristics of 
particulate drug formulations to develop formulations 
suitable for automated capsule filling. 
 
INTRODUCTION 
 Encapsulation of pharmaceutical formulations as liquids 
or semisolids, within hard gelatin capsules, allows for the 
oral delivery of poorly water-soluble active pharmaceutical 
ingredients (API), resulting in good bioavailability and 
reproducible absorption of the drug [1]. For automated 
capsule filling, rheological characteristics are critical and the 
working range is limited by the setup of the machine. 
Rheology-related problems encountered during capsule 
filling can include spatter and dripping. For a dispersion of 
solid drug particles in the excipient, the rheology is affected 
by the properties of the disperse phase (particle size, 
concentration) and the continuous phase (viscosity), leading 
to filling limitations. 
 The aim of this work was to investigate the rheological 
characteristics of particulate formulations to guide 
formulation development for an oral drug product for use in 
clinical trial.  
 
MATERIALS AND METHODS 
 Rheological analysis was performed using a Haake 
Mars rheometer (Thermo Scientific) in conjunction with a 
2.0 cm stainless steel parallel plate test geometry. The 
rheological flow behaviour was analysed using flow runs 
from 0 to 240 s-1 over 30 s and the apparent viscosity was 
measured (in triplicate) at 140 s-1. API particle diameter was 
microscopically estimated as less than 50ȝm. Automated 
capsule filling was performed with a Capsugel CFS1000 
capsule filling machine.  
   
RESULTS AND DISCUSSION 
 Excipients compatible with hard gelatin capsules and 
particulate drug formulations thereof were rheologically 
characterised. Apparent viscosity was markedly increased in 
presence of particulate API (Table 1). Low (5 wt% API) and 
high (30wt%) strength formulations were required to cover 
the expected dose range for a clinical trial, both showing 
their own limitations.  
 Initial experiments with Kollisolv P124 showed that 
high apparent viscosities (>610mPa.s) showed good flow 
and dosing in the capsule filling machine. High viscosity 
formulations were also preferable because of their improved 
ability to keep drug particles in suspension for longer. For 
the high strength formulation, PEG300 was added to adjust 
the viscosity of Kollisolv/API to the working range of the 
capsule filling machine. 
 
Table 1. Apparent viscosities (at a shear rate of 140 s-1) of excipients in 
absence/presence of particulate API. Low strength and high strength 
formulations are compared. Highlighted areas indicate suitability within the 
viscosity working range (10 - 1000 mPa.s [1]) of the capsule filling 
machine. Green (red) framed results indicate good (unsatisfactory) filling in 
the capsule filling machine. 
 
Formulation T (deg C) Apparent viscosity   (mPa.s) 
  
no API 5 wt% API 30 wt% API 
Kollisolv P124 20 897 1111 6626 
 
35 289 422 - 
 
40 245 295 2243 
Kollisolv P124/ 20 459 493 3713 
PEG300 40 167 201 1537 
 (70:30) 50 - - 1170 
  60 81 - 726 
Labrasol 20 89 - 1048 
Gelucire 44/14 40 139 - 1310 
 
50 91 107 - 
 
60 69 - 710 
  65 55 73 - 
Miglyol 812 N 20 29 - 302 
 
 
Good filling with the capsule filling machine was achieved 
with Kollisolv P124 based formulations, for both low and 
high strength API formulations. Capsule filling of low 
viscosity particulate formulations (5wt% API in Gelucire) 





x Rheology is a critical parameter for automated capsule 
filling of particulate formulations. 
x High viscosity formulations (but within the working 
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